KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $59.2M invested in KalVista Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4.31% more ownership

Funds ownership: 73.83% → 78.14% (+4.3%)

0% more funds holding

Funds holding: 20 → 20 (0)

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.11M
2
+$766K
3
+$86K
4
BFM
Boothbay Fund Management
New York
+$41.5K
5
BlackRock
BlackRock
New York
+$27K

Top Sellers

1
-$14.9K
2
-$1.3K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$22.7M
2
$20.1M
3
$4.62M
4
$2.58M
5
$2.52M
6
$2.35M
7
$1.64M
8
$1.41M
9
$766K
10
$169K
11
$88K
12
$86K
13
$85K
14
$27K
15
$18K
16
$6K
17
$3K
18
$1K
19
–